Enolase
Enolase is an enzyme that plays a critical role in the glycolysis and gluconeogenesis pathways. It catalyzes the conversion of 2-phosphoglycerate (2-PG) to phosphoenolpyruvate (PEP) and vice versa. This reaction is essential for the metabolic processes that provide energy to cells.
Structure[edit]
Enolase is a metalloenzyme that requires Mg²⁺ as a cofactor for its activity. It is a dimeric enzyme, meaning it consists of two subunits. Each subunit has a binding site for the substrate and the cofactor. The enzyme is highly conserved across different species, indicating its importance in cellular metabolism.
Function[edit]
In the glycolytic pathway, enolase catalyzes the penultimate step, converting 2-phosphoglycerate to phosphoenolpyruvate. This reaction is crucial for the subsequent production of ATP, the energy currency of the cell. In gluconeogenesis, the reverse reaction occurs, contributing to the synthesis of glucose from non-carbohydrate precursors.
Clinical significance[edit]
Enolase has been studied as a potential biomarker for various diseases. For example, neuron-specific enolase (NSE) is used as a marker for certain types of cancer, including neuroblastoma and small cell lung cancer. Elevated levels of NSE in the blood can indicate the presence of these malignancies.
Isoforms[edit]
There are three isoforms of enolase in humans: alpha, beta, and gamma. Each isoform is expressed in different tissues and has distinct physiological roles. Alpha-enolase is ubiquitous, beta-enolase is found primarily in muscle tissue, and gamma-enolase is predominantly expressed in neurons.
Regulation[edit]
The activity of enolase is regulated by various factors, including the availability of its substrate and cofactor, as well as by post-translational modifications. Phosphorylation and acetylation are known to affect enolase activity and stability.
Enolase gallery[edit]
-
Enolase with differentiated subunits -
Enolase active site -
Enolase mechanism2
See also[edit]
| Enzymes | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
